Skip to content

Diabetes Management Intervention For South Asians

Diabetes Management Intervention For South Asians

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03333044
Enrollment
859
Registered
2017-11-06
Start date
2019-07-11
Completion date
2024-06-30
Last updated
2025-09-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes, HbA1c

Brief summary

The goal of this study is to evaluate the effectiveness and implementation process of a multi-level, integrated intervention to decrease HbA1c among South Asians with uncontrolled diabetes, including four components: 1) an EHR-based registry function to increase identification of South Asian patients with uncontrolled diabetes; 2) CHW-led health coaching of registered patients to promote health behavior change; 3) HIT-enabled and CHW-facilitated identification and referral to culturally relevant community resources for patients; and 4) HIT-enabled care coordination between the CHW and other members of the healthcare team.

Interventions

BEHAVIORALCommunity Health Worker (CHW)-Led Health Coaching

CHW intervention includes a protocol that consists of 5 monthly 90-minute group health education sessions, providing the tools and strategies to manage diabetes.

OTHEREHR-Embedded Alerts

An electronic health record (EHR) intervention for primary care providers (PCPs) utilizing embedded alerts to identify South Asian patients with uncontrolled diabetes.

Sponsors

National Institute on Minority Health and Health Disparities (NIMHD)
CollaboratorNIH
NYU Langone Health
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* South Asian ethnicity (identified through a race and language code available in the EHR); * an appointment with a physician for routine non-emergent primary care in the last 12 months * diagnosis of diabetes * an HbA1c reading of \>7 in the last 12 months

Exclusion criteria

* Pregnant women and visits to obstetrician/gynecologist are excluded from the study

Design outcomes

Primary

MeasureTime frameDescription
Percentage of Participants Who Had at Least a 0.5% Reduction in HbA1c From Baseline 6 MonthsBaseline, Month 6Measured via complete lipoprotein panel.

Countries

United States

Participant flow

Pre-assignment details

Primary care providers (PCPs) were not considered enrolled in this study.

Participants by arm

ArmCount
Wait-List Control
Participants in the wait-list control group will be receive care as usual during the first round for data abstraction and offered CHW group education sessions during the second round as a point of service (i.e., not for research purposes).
419
CHW-Led Health Coaching
Participants in the treatment group will be randomized to receive the CHW group education session intervention in either the first or second round. Community Health Worker (CHW)-Led Health Coaching: CHW intervention includes a protocol that consists of 5 monthly 90-minute group health education sessions, providing the tools and strategies to manage diabetes. EHR-Embedded Alerts: An electronic health record (EHR) intervention for primary care providers (PCPs) utilizing embedded alerts to identify South Asian patients with uncontrolled diabetes.
419
Total838

Withdrawals & dropouts

PeriodReasonFG000FG001FG002
Overall StudyLost to Follow-up0146
Overall StudyPregnancy100

Baseline characteristics

CharacteristicWait-List ControlTotalCHW-Led Health Coaching
Age, Continuous55.1 years
STANDARD_DEVIATION 9.7
55.1 years
STANDARD_DEVIATION 9.7
55.1 years
STANDARD_DEVIATION 9.7
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants0 Participants0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
419 Participants838 Participants419 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
419 Participants838 Participants419 Participants
Race (NIH/OMB)
Black or African American
0 Participants0 Participants0 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
0 Participants0 Participants0 Participants
Region of Enrollment
United States
419 participants838 participants419 participants
Sex: Female, Male
Female
222 Participants445 Participants223 Participants
Sex: Female, Male
Male
197 Participants393 Participants196 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 4190 / 440
other
Total, other adverse events
0 / 4190 / 440
serious
Total, serious adverse events
0 / 4190 / 440

Outcome results

Primary

Percentage of Participants Who Had at Least a 0.5% Reduction in HbA1c From Baseline 6 Months

Measured via complete lipoprotein panel.

Time frame: Baseline, Month 6

ArmMeasureValue (NUMBER)
Wait-List ControlPercentage of Participants Who Had at Least a 0.5% Reduction in HbA1c From Baseline 6 Months32.1 Percentage of participants
CHW-Led Health CoachingPercentage of Participants Who Had at Least a 0.5% Reduction in HbA1c From Baseline 6 Months35.2 Percentage of participants

Source: ClinicalTrials.gov · Data processed: Feb 20, 2026